Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof

Inactive Publication Date: 2013-06-13
SHIONOGI & CO LTD +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

These compounds provide effective blockade of N-type calcium channels, offering therapeutic benefits for pain management, neuroprotection, and treatment of neurological disorders while minimizing the risk of hypotensive effects associated with L-type channel inhibition.

Problems solved by technology

However, inhibition of cardiac L-type calcium channels can lead to hypotension.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof
  • Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof
  • Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

N-Cyclopropyl-6-(1,2,3,6-tetrahydropyridin-4-yl)picolinamide hydrochloride (5)

[0363]

[0364]a) To a stirred suspension of compound 1 (500 mg, 3.18 mmol, Aldrich), 1-hydroxybenzotriazole hydrate (HOBt) (430 mg, 3.18 mmol, Aldrich), and N-(3-dimethylaminopropyl)N′ethylcarbodiimide hydrochloride (EDCl) (672 mg, 3.50 mmol, Aldrich) in dichloromethane was added sequentially diisopropyl ethyl amine (1.1 ml, 6.4 mmol) and cyclopropyl amine (245 μl, 3.5 mmol, Aldrich). The resulting mixture was slowly warmed to room temperature and stirred for 12 hours. The crude mixture was purified on CombiFlash® (Teledyne Isco, Inc., Lincoln, Nebr.) with a gradient of 20% to 80% EtOAc in hexane to provide compound 2 as a white solid (483 mg, yield 77%).

[0365]b) The suspension of compound 2 (180 mg, 0.92 mmol), 3,6-dihydro-2H-pyridine-1-tert-butoxycarbonyl-4-boronic acid pinacol ester (3) (284 mg, 0.92 mmol, Carbocore), potassium carbonate (254 mg, 1.84 mmol) and palladium bistriphenylphosphine dichloride (...

example 2

1′-(3-Trifluoromethylbenzenesulfonyl)-1′,2′,3′,6′-tetrahydro-[2,4′]bipyridinyl-6-carboxylic acid cyclopropylamide (7)

[0367]

[0368]Diisopropyl ethyl amine (66 ml, 0.36 mmol) and 3-(trifluoromethyl)benzene sulfonyl chloride (6) (44 mg, 0.18 mmol, Aldrich) were sequentially added to a suspension of compound 5 (50 mg, 0.18 mmol) in dichloromethane at 0° C. while stirring. The reaction was completed within 0.5 hour and the crude product was purified without work-up on CombiFlash® with a gradient of 50-100% EtOAc in hexane to provide the title compound 7 as a white solid (50 mg, yield 64%). 1H NMR (400 MHz, CD3OD): δ 8.15 (m, 2H), 8.02-7.83 (m, 4H), 7.67 (dd, 1H, J=1.2, 7.6 Hz), 6.78 (m, 1H), 3.92 (m, 2H), 3.45 (m, 2H), 2.87 (m, 1H), 2.77 (m, 2H), 0.86 (m, 2H), 0.70 (m, 2H); MS: 452 (M+H+), 474 (M+Na).

[0369]Similarly, the following compounds were prepared by reacting compound 5 with an appropriate reagent (in parenthesis):

[0370]1′-(4-Trifluoromethoxybenzenesulfonyl)-1′,2′,3′,6′-tetrahydro-...

example 3

[0390]1′-(4-Trifluoromethoxybenzyl)-1′,2′,3′,6′-tetrahydro-[2,4′]bipyridinyl-6-carboxylic acid cyclopropylamide (9)

[0391]1′-(4-Trifluoromethoxybenzyl)-1′,2′,3′,6′-tetrahydro-[2,4′]bipyridinyl-6-carboxylic acid cyclopropylamide (9) was prepared by adding diisopropyl ethyl amine to a suspension of compound 5 (72 mg, 0.25 mmol), 4-trifluoromethoxybenzaldehyde (8) (Aldrich) and 3 Å molecular sieves (200 mg, Aldrich). The mixture was stirred for 12 hours and NaCNBH3 was added. The crude product was filtered and then purified on Prep TLC (10% MeOH in dichloromethane with 1% NH4OH) to provide the title compound 9 (25 mg, yield 23%): 1H NMR (400 MHz, CD3OD, HCl-salt): δ 8.48 (bd, 1 h, NH), 7.88 (d, 1H, J=7.6 Hz), 7.83 (t, 1H, J=7.6 Hz), 7.65 (d, 1H, J=7.6 Hz), 7.57 (m, 2H), 7.32 (d, 2H, J=8.8 Hz), 6.68 (m, 1H), 4.39 (m, 2H), 3.85 (m, 2H), 3.68 (m, 1H), 3.26 (m, 1H), 3.12 (m, 1H), 2.82 (m, LH), 2.71 (m, 1H), 0.72 m, 2H), 0.54 (m, 2H); MS: 418.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to tetrahydropyridinyl and dihydropyrrolyl compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein X, Y, Z, R1, R2, m, and n are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]This invention is in the field of medicinal chemistry. The invention relates to novel tetrahydropyridinyl and dihydropyrrolyl compounds and the use of these compounds as blockers of calcium (Ca2+) channels.[0003]2. Background Art[0004]Calcium ions play fundamental roles in the regulation of many cellular processes. It is therefore essential that their intracellular levels be maintained under strict, yet dynamic control (Davila, H. M., Annals of the New York Academy of Sciences, pp. 102-117 (1999)). Voltage-gated calcium channels (VGCC) serve as one of the important mechanisms for fast calcium influx into the cell. Calcium channels are hetero-oligomeric proteins consisting of a pore-forming subunit (a 1), which is able to form functional channels on its own in heterologous expression systems, and a set of auxiliary or regulatory subunits. Calcium channels have been classified based on their pharmacological and / or electro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07D401/04C07D413/04C07D413/14C07D451/02
CPCC07D401/04C07D401/14C07D451/02C07D413/14C07D413/04A61P25/00A61P25/04A61P25/06A61P25/08A61P25/18A61P25/22A61P25/24A61P25/28A61P29/00A61P43/00A61P9/00A61P9/06A61P9/10A61P9/12
InventorMIKAMIYAMA, HIDENORINI, CHIYOUSHAO, BINTAFESSE, LAYKEA
OwnerSHIONOGI & CO LTD